Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case
- 1 October 2005
- journal article
- case report
- Published by Elsevier in Human Pathology
- Vol. 36 (10) , 1148-1151
- https://doi.org/10.1016/j.humpath.2005.07.020
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The 8;21 translocation in leukemogenesisOncogene, 2004
- The 8p11 Myeloproliferative Syndrome: A Distinct Clinical Entity Caused by Constitutive Activation of FGFR1Acta Haematologica, 2002
- The erythropoietin receptorSeminars in Oncology, 2001
- Fusion of TEL, the ETS-Variant Gene 6 (ETV6), to the Receptor-Associated Kinase JAK2 as a Result of t(9; 12) in a Lymphoid and t(9; 15; 12) in a Myeloid LeukemiaBlood, 1997
- The Structure, Regulation and Function of the Janus Kinases (JAKs) and the Signal Transducers and Activators of Transcription (STATs)European Journal of Biochemistry, 1997
- Association of JAK2 and STAT5 with Erythropoietin ReceptorsJournal of Biological Chemistry, 1996
- Interleukin-5 and its receptor: a drug target for eosinophilia associated with chronic allergic diseaseJournal of Leukocyte Biology, 1995
- Myelodysplastic Syndrome with Bone Marrow Eosinophilia: Clinical and Cytogenetic FeaturesLeukemia & Lymphoma, 1994